Dr. Bob Ryder
Co-opted Website Co-ordinator & Clinical Lead, Nationwide Audits of New Diabetes Therapies
Bob Ryder trained in South Wales and Sheffield. He has worked as a Consultant Physician/Diabetologist/Endocrinologist, City Hospital, Birmingham since 1991. Over the years special interests have included diabetic retinopathy screening; diabetic hypoglycaemia unawareness; diabetic autonomic neuropathy; diabetic impotence; clinical use of IT; treating to target; relative risks and benefits of pioglitazone He leads the ABCD nationwide audits of new therapies and devices – current audits include SGLT2i, FreeStyle Libre, semaglutide, COVID 19 and diabetes, testosterone, closed-loop systems, oral semaglutide and Omnipod. He is chief investigator of two ABCD Endobarrier studies (https://youtu.be/xRcnMBOdb58, https://youtu.be/y1zm0Scq6YM). Beyond diabetes he is best known as principal author of best-selling "An Aid to the MRCP Short Cases", the 4th-edition of which is the three volume “An Aid to the MRCP PACES”.
Become a Member
The Association of British Clinical Diabetologists is the national organisation of Consultant Physicians in Britain who specialise in Diabetes Mellitus. Most are also Acute General Physicians, and many are also Specialists in Endocrinology and Lipid Metabolism.
